Executive Summary: This is a business plan of Square Pharmaceuticals Limited, which is a flagship company in the pharmaceuticals industry and

it is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985. This business plan clearly states the vision, mission and objectives of Square pharmaceutical Limited. It also discusses the SWOT analysis and the various marketing strategies (4 Ps) of this company. It gives a clear financial report so that the performance of this most renowned company can be evaluated. Other than that it clearly shows the management organogram of this firm. INRODUCTION: Square Pharmaceuticals Limited is a renowned company in Bangladesh. It is a flagship company in the pharmaceutical industry, which has reached this mountain of success by fighting many potential competitors like BEXIMCO Pharma, INCEPTA, ACME, RENETA, OPSONIN, SK+F, and SANOFI-AVENTIS etc. Samson H.Chowdhury founded the company in 1958 along with three of his friends as a private firm. It went public in 1991 and is currently listed on the Dhaka Stock Exchange. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and it has been continuously in the 1st position among all national and multinational companies since 1985. Square Pharmaceuticals Ltd. is now on its way to becoming a high performance global player. MAJOR GOALS AND OBJECTIVES: VISION: Square Pharmaceuticals Ltd views business as a means to the material and social well being of the investors, employees and the society at large, leading to accretion of wealth through financial and moral gains as a part of the process of the human civilization. MISSION: The Mission of Square Pharmaceuticals Ltd is to produce and provide quality & innovative healthcare relief for people, maintain stringently ethical standard in business operation also ensuring benefit to the shareholders, stakeholders and the society at large. OBJECTIVE: The objectives of Square Pharmaceuticals Ltd are to conduct transparent business operation based on market mechanism within the legal & social framework with aims to attain the mission reflected by our vision. SWOT ANALYSIS: Strength: It is only the Square pharmaceuticals ltd that has various product lines compared to its rivals. Unlike It is rivals it produces various kinds of medicines to focus and meet the different needs of the consumers.

Annually it spends a huge amount of money only in product innovations and every time it comes up with a new innovation compared to its competitors to fill the untouched market segments. The marketing policies and strategies used are so effective and innovative that it is now considered as the flagship company and it is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and it has been continuously in the 1st position among all national and multinational companies since 1985. Due to its strong brand image it is always the first preference for potential consumers. Weakness: Square Pharmaceuticals has huge product lines, and it is almost impossible to operate each of the product line with equal efficiency. Opportunity: Nowadays the population of Bangladesh is rising tremendously. A large population means greater pollution, a greater pollution results various diseases, and so it has a great opportunity to expand its sales due to the persistent increase in the population. These days preservatives are almost used in daily food items, so there's increasing demand of preservatives, and so it is an opportunity for Square pharmaceuticals to expand it's sales. On the other hand the consumption of food items containing preservatives results in various kinds of diseases that in turn acts as an opportunity in the expansion of its sales Threat: Many competitors do exist in the pharmaceuticals industries and in future they may expand in order to have head-to-head competition with Square pharmaceuticals. And if the other firms get more efficient than Square pharmaceuticals in future so Square may forfeit it's market share to a greater extend.